Rolapitant hydrochloride

Rolapitant hydrochloride (anhydrous) is a hydrochloride obtained by combining irinotecan with one molar equivalent of hydrochloric acid. Used (in the form of the hydrate) for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy. Among its listed roles, it functions as a antiemetic and a neurokinin-1 receptor antagonist. It includes a rolapitant. It is grouped under the following drug class(es): Antiemetics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Varubi and TS-08867. Its PubChem CID is 71587824.

CAS No 858102-79-1
Molecular Formula C25H27ClF6N2O2
Molecular Weight 536.9 g/mol
Synonyms (5S,8S)-8-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-8-phenyl-1,9-diazaspiro[4.5]decan-2-one;hydrochloride

Frequently Asked Questions